William Nyhan
This article may meet Wikipedia's criteria for speedy deletion as an article that contains no content whatsoever, or consists only of external links, categories, a "see also" section, a rephrasing of the title, chat-like comments, template tags, and/or images. Disambiguation pages and redirects are not eligible for this criterion. A very short article may still be a valid stub if there is sufficient context to identify the subject. See CSD A3.
If this article does not meet the criteria for speedy deletion, or you intend to fix it, please remove this notice, but do not remove this notice from pages that you have created yourself. If you created this page and you disagree with the given reason for deletion, you can click the button below and leave a message explaining why you believe it should not be deleted. You can also visit the talk page to check if you have received a response to your message. Note that this article may be deleted at any time if it unquestionably meets the speedy deletion criteria, or if an explanation posted to the talk page is found to be insufficient.
Note to administrators: this article has content on its talk page which should be checked before deletion. Administrators: check links, talk, history (last), and logs before deletion. Consider checking Google.This page was last edited by Larsie (contribs | logs) at 18:03, 13 April 2006 (UTC) (18 years ago) |
Dr. William Nyhan, M.D., PH.D, UCSD School of Medicine, La Jolla, California
Dr. William Nyhan currently holds the position of Professor of Pediatrics at UCSD School of Medicine in La Jolla, Ca. Previous work has been done at Johns Hopkins University School of Medicine, University of Miami School of Medicine, and in addition he has served on a number of advisory committees, pediatric advisory boards, and research foundations. Over 56 years of experience and interests in areas of research span a wide variety of disorders of amino acid metabolism, including 4-Hydroxybutyric aciduria, 3-methylglutaconyl-Co A hydratase deficiency, multiple carboxylase deficiency, methylmalonic acidemia, propionic acidemia, and also the identification of Lesch-Nyhan syndrome. He is currently involved in the ongoing development of tandem mass spectrometry for use in newborn screening and research, and is involved in identifying the cause(s) of progressive neurologic disability in MMA after liver transplantation. Dr. Nyhan has studied the neuropathology of propionic acidemia including the manifestation of basal ganglia infarction and the neurologic non-metabolic presentation of PA.Current research includes evaluating the use of dichloroacetate (DCA) in treating a broad range of patients with mitochondrial disease leading to lactic acidemia.